pubmed-article:2669334 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2669334 | lifeskim:mentions | umls-concept:C0020094 | lld:lifeskim |
pubmed-article:2669334 | lifeskim:mentions | umls-concept:C0013018 | lld:lifeskim |
pubmed-article:2669334 | lifeskim:mentions | umls-concept:C0178913 | lld:lifeskim |
pubmed-article:2669334 | lifeskim:mentions | umls-concept:C0003253 | lld:lifeskim |
pubmed-article:2669334 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
pubmed-article:2669334 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:2669334 | pubmed:dateCreated | 1989-9-15 | lld:pubmed |
pubmed-article:2669334 | pubmed:abstractText | Sera from 867 donors were tested for antibodies to the virus of T-lymphocyte leukemia of adults (HTLV-I) in parallel by indirect immunofluorescence on acetone-fixed cells of HUT-102 culture producing HTLV-I and by agglutination test using a commercial set ("Serodia-ATLA", Japan). Twelve (1.38%) out of 867 sera were positive in the agglutination test and only 7 of them in immunofluorescence test. The specificity of the results was verified by absorption experiments. The activity of the sera in the agglutination test disappeared completely after their absorption with HUT-102 culture cells but did not change after absorption with LLU cells producing no HTLV-I despite a low percent of virus infection, donor blood control for HTLV-I infection becomes mandatory. | lld:pubmed |
pubmed-article:2669334 | pubmed:language | rus | lld:pubmed |
pubmed-article:2669334 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2669334 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2669334 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2669334 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2669334 | pubmed:issn | 0507-4088 | lld:pubmed |
pubmed-article:2669334 | pubmed:author | pubmed-author:StepinaV NVN | lld:pubmed |
pubmed-article:2669334 | pubmed:author | pubmed-author:IakovlevaL... | lld:pubmed |
pubmed-article:2669334 | pubmed:author | pubmed-author:GurtsevichV... | lld:pubmed |
pubmed-article:2669334 | pubmed:author | pubmed-author:SeniutaN BNB | lld:pubmed |
pubmed-article:2669334 | pubmed:author | pubmed-author:BuachidzeL... | lld:pubmed |
pubmed-article:2669334 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2669334 | pubmed:volume | 34 | lld:pubmed |
pubmed-article:2669334 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2669334 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2669334 | pubmed:pagination | 174-6 | lld:pubmed |
pubmed-article:2669334 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:2669334 | pubmed:meshHeading | pubmed-meshheading:2669334-... | lld:pubmed |
pubmed-article:2669334 | pubmed:meshHeading | pubmed-meshheading:2669334-... | lld:pubmed |
pubmed-article:2669334 | pubmed:meshHeading | pubmed-meshheading:2669334-... | lld:pubmed |
pubmed-article:2669334 | pubmed:meshHeading | pubmed-meshheading:2669334-... | lld:pubmed |
pubmed-article:2669334 | pubmed:meshHeading | pubmed-meshheading:2669334-... | lld:pubmed |
pubmed-article:2669334 | pubmed:meshHeading | pubmed-meshheading:2669334-... | lld:pubmed |
pubmed-article:2669334 | pubmed:meshHeading | pubmed-meshheading:2669334-... | lld:pubmed |
pubmed-article:2669334 | pubmed:meshHeading | pubmed-meshheading:2669334-... | lld:pubmed |
pubmed-article:2669334 | pubmed:meshHeading | pubmed-meshheading:2669334-... | lld:pubmed |
pubmed-article:2669334 | pubmed:meshHeading | pubmed-meshheading:2669334-... | lld:pubmed |
pubmed-article:2669334 | pubmed:meshHeading | pubmed-meshheading:2669334-... | lld:pubmed |
pubmed-article:2669334 | pubmed:meshHeading | pubmed-meshheading:2669334-... | lld:pubmed |
pubmed-article:2669334 | pubmed:articleTitle | [Detection of HTLV-I viral antibodies in donor blood samples]. | lld:pubmed |
pubmed-article:2669334 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2669334 | pubmed:publicationType | English Abstract | lld:pubmed |